Azienda Ospedaliera Santa Maria di Terni

Terni, Umbria 20089

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Melanoma, Muscle-invasive Bladder Cancer, Ovarian Cancer, Prostate Cancer

Studies at this site

• A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Participants With High-risk Muscle-invasive Bladder Cancer (MIBC) Who Are ctDNA Positive Following Cystectomy — Running, not enrolling
• Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma — Completed
• A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer. — Completed